• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AIZU OLYMPUS CO., LTD. EVIS EXERA DUODENOVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AIZU OLYMPUS CO., LTD. EVIS EXERA DUODENOVIDEOSCOPE Back to Search Results
Model Number TJF-160VF
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Perforation (2001); Pancreatitis (4481)
Event Date 09/07/2021
Event Type  Injury  
Event Description
Olympus reviewed the following literature titled "artificial intelligence for automatic diagnosis of biliary stricture malignancy status in single-operator cholangioscopy: a pilot study".The aim of this study was to develop and validate a convolutional neural networks (cnn)-based algorithm for the automatic detection and differentiation of malignant biliary strictures and benign biliary lesions in digital single-operator cholangioscopy (dsoc) images.A total of 85 patients underwent dsoc (40 (47%) patients had diagnosed with benign disease whereas 45 (53%) were ultimately diagnosed with a malignant biliary stricture).Overall, the estimated model accuracy was 94.9% (95% ci, 92.4%-97.4%).The mean sensitivity and specificity of the model were 94.7% (95% ci, 90.5%-98.9%) and 92.1% (95% ci, 89.4% ¿ 94.6%).The algorithm had a mean auc of 0.988 (95% ci, 0.982-0.994).The sensitivity, specificity, ppv and npv for the detection and differentiation of malignant strictures from benign biliary disease were, respectively, 94.8%, 99.1%, 99.8%, and 80.8%.The introduction of artificial intelligence algorithms to dsoc systems may significantly increase its diagnostic yield for malignant strictures.Type of adverse events/number of patients: [malignant strictures]; cholangitis - 4 patients, pancreatitis - 9 patients, perforation - 1 patient, bacteremia - 1 patient.[benign strictures]: cholangitis - 3 patients, pancreatitis - 5 patients.This literature article requires 2 reports.The related patient identifiers are as follows: (b)(6)(tjf-160vf).(b)(6)(tjf-q180v).This medwatch report is for patient identifier (b)(6).There is no report of any olympus device malfunction in any procedure described in this study.
 
Manufacturer Narrative
The suspect device has not been returned to olympus for evaluation.The investigation is in process.The literature article https://doi.Org/10.1016/j.Gie.2021.08.027 provided for additional information.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
 
Event Description
The customer confirms that no olympus device malfunction during any procedure described in this literature and no olympus device cause or contribute to any of the patient adverse events described in this literature.
 
Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation and to provide follow up received from the customer.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse events cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.Olympus will continue to monitor field performance for this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS EXERA DUODENOVIDEOSCOPE
Type of Device
DUODENOVIDEOSCOPE
Manufacturer (Section D)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima 965-8 520
JA  965-8520
Manufacturer (Section G)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key16942238
MDR Text Key315332363
Report Number9610595-2023-07534
Device Sequence Number1
Product Code FDT
Combination Product (y/n)N
Reporter Country CodePO
PMA/PMN Number
K024033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/23/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberTJF-160VF
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 04/17/2023
Initial Date FDA Received05/16/2023
Supplement Dates Manufacturer Received06/12/2023
Supplement Dates FDA Received06/23/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
-
-